Press release

Bio-Conscious integrates GPT-4 into Endobits V5

Endobits AI Assist drafts chart notes from CGM data and gives clinicians in-context access to American Diabetes Association guidance.

Published · Bio-Conscious Technologies

Vancouver, BC and Houston, TX. Bio-Conscious announced the integration of GPT-4 into Endobits V5. The assistant drafts personalized chart notes from a patient's continuous glucose data and puts current American Diabetes Association guidance in front of the clinician while they work, cutting the administrative load on doctors and nurses.

"We are at an inflection point in LLMs, and the integration of GPT-4 with our Endobits ARPM software is one of the most practical use cases," said Amir Hayeri, Founder and CEO. Dr. Jerome Fischer, Chief Medical Officer, added that the assistant "can support doctors and nurses by providing access to the latest guidelines."

Read the full release on ACCESS Newswire

← All news

Get Bio-Conscious in your Google results. Add us as a preferred source and our latest research and guides surface first in Top Stories.